Amgen Licenses Stem Cell Growth Factors to ViaCell

By Business Review Editor

Pharma Deals Review: Vol 2004 Issue 44 (Table of Contents)

Published: 4 Feb-2004

DOI: 10.3833/pdr.v2004.i44.830     ISSN: 1756-7874

Section: Licensing



ViaCell licensed several stem cell growth factors from Amgen, in a deal that provides the world’s largest biotechnology company with the right to commercialize the cellular therapy products that result from the collaboration...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details